Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
Clinical trial NCT01443364 · COMPLETED
Trial details
- NCT number
- NCT01443364
- Sponsor
- UCB Italy s.p.a.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-05-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.